PCSA Processa Pharmaceuticals, Inc.: institutional ownership and insider trading
13 funds reported holding $566K of Processa Pharmaceuticals, Inc. in their latest 13F filings; in Q2 2026 funds net bought $149K, with 4 new positions and 2 funds selling out; over the last 12 months insiders bought $203K and sold $0 on the open market.
Famous investors holding PCSA
- Ken Griffin (Citadel Advisors): $40.9K, 0.0% of the portfolio
Largest institutional holders of PCSA
- Connective Capital Management, LLC — $164K
- Stonepine Capital Management, LLC — $106K
- VANGUARD GROUP INC — $67.9K
- GEODE CAPITAL MANAGEMENT, LLC — $42.4K
- CITADEL ADVISORS LLC — $40.9K
- StoneX Group Inc. (SNEX) — $29.6K
- XTX Topco Ltd — $25.5K
- JANE STREET GROUP, LLC — $25.5K
- VANGUARD CAPITAL MANAGEMENT LLC — $24.4K
- VANGUARD FIDUCIARY TRUST CO — $20.8K
Recent PCSA insider trades
- Jul 1, 2026: Ng George K bought 3,057 shares ($5.90K)
- Jun 30, 2026: Young David bought 2,531 shares ($4.89K)
- Jun 30, 2026: Skibsted Russell bought 3,277 shares ($6.33K)
- Jun 30, 2026: Lin Patrick bought 2,106 shares ($4.07K)
5%+ owners
- CVI Investments, Inc.: 7.0% (Schedule 13G/A, filed May 15, 2026)
- Soleus Capital Master Fund, L.P.: 5.8% (Schedule 13G, filed Aug 18, 2026)